In:
Diabetes, Obesity and Metabolism, Wiley, Vol. 18, No. 5 ( 2016-05), p. 500-507
Abstract:
To compare insulin pump therapy and multiple daily injections ( MDI ) in patients with type 2 diabetes receiving basal and prandial insulin analogues. Methods After a 2‐month dose‐optimization period, 331 patients with glycated haemoglobin ( HbA1c ) levels ≥8.0% and ≤12% were randomized to pump therapy or continued MDI for 6 months [randomization phase ( RP )]. The MDI group was subsequently switched to pump therapy during a 6‐month continuation phase ( CP ). The primary endpoint was the between‐group difference in change in mean HbA1c from baseline to the end of the RP . Results The mean HbA1c at baseline was 9% in both groups. At the end of the RP , the reduction in HbA1c was significantly greater with pump therapy than with MDI (−1.1 ± 1.2% vs −0.4 ± 1.1%; p 〈 0.001). The pump therapy group maintained this improvement to 12 months while the MDI group, which was switched to pump therapy, showed a 0.8% reduction: the final HbA1c level was identical in both arms. In the RP , total daily insulin dose ( TDD ) was 20.4% lower with pump therapy than with MDI and remained stable in the CP . The MDI –pump group showed a 19% decline in TDD , such that by 12 months TDD was equivalent in both groups. There were no differences in weight gain or ketoacidosis between groups. In the CP , one patient in each group experienced severe hypoglycaemia. Conclusions Pump therapy has a sustained durable effect on glycaemic control in uncontrolled type 2 diabetes.
Type of Medium:
Online Resource
ISSN:
1462-8902
,
1463-1326
DOI:
10.1111/dom.2016.18.issue-5
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
2004918-3
Permalink